Ftse Mib
35.013,84
-1,09%
DAX
18.764,78
0,31%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.941,45
1,18%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSX Theratechnologies Inc (TH) Theratechnologies Inc (TH) Notizie

TH

Theratechnologies (TH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:TH
DataOraFonteTitoloSimboloCompagnia
02/01/202415:00AllPennyStocks.comWill This Dual-Listed Bio-Pharma Catch New Year Action?TSX:THTheratechnologies Inc
21/12/202322:12PR Newswire (Canada)Theratechnologies annonce le renouvellement de son prospectus préalable et le dépôt de sa déclaration d'inscriptionTSX:THTheratechnologies Inc
21/12/202322:09PR Newswire (US)Theratechnologies Announces Renewal of Shelf Prospectus and Filing of Registration StatementTSX:THTheratechnologies Inc
21/08/202321:24PR Newswire (Canada)Toronto Stock Exchange, Theratechnologies Inc., View From The C-SuiteTSX:THTheratechnologies Inc
31/07/202315:00AllPennyStocks.comBiopharma Firm Completes Reverse Stock SplitTSX:THTheratechnologies Inc
19/05/202323:11PR Newswire (Canada)Early Warning Report Issued Pursuant to National Instrument 62-103 - Acquisition of Securities of Theratechnologies Inc.TSX:THTheratechnologies Inc
27/04/202213:30PR Newswire (US)THERATECHNOLOGIES TO FOCUS ITS COMMERCIALIZATION ACTIVITIES ON THE NORTH AMERICAN TERRITORYTSX:THTheratechnologies Inc
27/04/202213:30PR Newswire (Canada)THERATECHNOLOGIES ANNONCE SON INTENTION DE CONCENTRER SES ACTIVITÉS DE COMMERCIALISATION SUR LE TERRITOIRE NORD-AMÉRICAINTSX:THTheratechnologies Inc
23/11/202115:48PR Newswire (Canada)Theratechnologies annonce le renouvellement de son prospectus préalable et de sa déclaration d'inscription; le programme de placements d'actions au cours du marché sera prolongéTSX:THTheratechnologies Inc
23/11/202115:46PR Newswire (Canada)Theratechnologies Announces Renewal of Shelf Prospectus and Registration Statement; At-The-Market Facility to be ExtendedTSX:THTheratechnologies Inc
24/07/202101:36PR Newswire (Canada)Theratechnologies établit un programme de placements d'actions au cours du marchéTSX:THTheratechnologies Inc
24/07/202101:30PR Newswire (Canada)Theratechnologies Establishes New At-The-Market FacilityTSX:THTheratechnologies Inc
10/09/202016:08PR Newswire (US)Theratechnologies Announces Launch of Trogarzo® in GermanyTSX:THTheratechnologies Inc
02/03/202014:00PR Newswire (Canada)Changement à la direction de TheratechnologiesTSX:THTheratechnologies Inc
02/03/202014:00PR Newswire (Canada)Change to Theratechnologies ManagementTSX:THTheratechnologies Inc
26/09/201915:00PR Newswire (Canada)Toronto Stock Exchange Introduces the TSX30TSX:THTheratechnologies Inc
26/09/201915:00PR Newswire (Canada)La Bourse de Toronto lance le palmarès TSX 30TSX:THTheratechnologies Inc
25/02/201916:10PR Newswire (Canada)Aligo Innovation annonce l'acquisition par Theratechnologies de Katana Biopharma Inc, une compagnie de biotechnologie pour le...TSX:THTheratechnologies Inc
06/03/201821:32PR Newswire (US)Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo™ (ibalizumab-uiyk) Injection, the First HIV-1 In...TSX:THTheratechnologies Inc
06/03/201821:13PR Newswire (Canada)Theratechnologies annonce l'approbation par la FDA de la percée thérapeutique Trogarzo(MC) (ibalizumab-uiyk) injection, le ...TSX:THTheratechnologies Inc
06/03/201820:35PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - THTSX:THTheratechnologies Inc
06/03/201820:33PR Newswire (Canada)IIROC Trade Resumption - THTSX:THTheratechnologies Inc
06/03/201818:53PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - THTSX:THTheratechnologies Inc
06/03/201818:52PR Newswire (Canada)IIROC Trading Halt - THTSX:THTheratechnologies Inc
04/10/201713:00PR Newswire (US)Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017™TSX:THTheratechnologies Inc
24/07/201713:30PR Newswire (US)Theratechnologies Announces New Findings with the Investigational Antiretroviral Ibalizumab and with EGRIFTA® (tesamorelin f...TSX:THTheratechnologies Inc
16/05/201719:52PR Newswire (Canada)Les actionnaires élisent une nouvelle membre du Conseil au cours de l'assemblée annuelle de TheratechnologiesTSX:THTheratechnologies Inc
16/05/201719:14PR Newswire (Canada)Shareholders elect new Board member during Theratechnologies' annual meetingTSX:THTheratechnologies Inc
16/05/201718:32PR Newswire (Canada)Annonces en marge de l'assemblée annuelle de TheratechnologiesTSX:THTheratechnologies Inc
16/05/201718:27PR Newswire (Canada)Announcements in conjunction with Theratechnologies annual meetingTSX:THTheratechnologies Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:TH

La tua Cronologia

EU
PET6P
Banque Palatine null
USOTC
TGDLF
Tongdao Liepin (PK)
ASX
HMI
Hiremii
COIN
NTXXUST
NitroEx
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network